HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis
OBJECTIVE: Juvenile idiopathic arthritis (JIA) is a heterogeneous condition with very few clinical and laboratory signs that can help predict the course and severity of the disease in the individual patient. The cell-surface antigen HLA-B27 is well known to be associated with spondyloarthropathies, reactive arthritis, and enthesitis. HLA-B27 plays an important role in the classification of JIA, since evidence of sacroiliitis most often evolves after years of arthritis in other joints. We investigated the associations of HLA-B27 and the clinical manifestations of JIA using a method as close to a population-based study as possible.
METHODS: We studied an incidence-based cohort of 305 patients collected prospectively in 3 Nordic countries (Sweden, Norway, Denmark). Clinical and serological data of the first 3 years of the disease were collected.
RESULTS: HLA-B27 was found to be positive in 25.5% of the patients, and we found a higher proportion of HLA-B27-positive boys with older age at disease onset (p=0.034). Regression analysis showed a correlation of 0.7 in the HLA-B27-positive boys, pointing to a higher risk of more joint involvement with older age at disease onset. By Fisher's exact test, involvement of small joints in the lower extremities was associated with HLA-B27 in boys (p=0.011), but not in girls (p=0.687). HLA-B27 was associated with inflammatory back pain in both sexes (p=0.041 in boys, p=0.042 in girls), but with enthesitis only in boys (p<0.001 in boys, p=0.708 in girls).
CONCLUSION: HLA-B27 is of increasing importance with older age at disease onset in boys with JIA, predicting more active joints within the first 3 years of disease, and also involving small joints in the lower extremity to a greater degree than in HLA-B27-negative boys. During the first 3 years of disease the occurrence of HLA-B27 is associated with inflammatory back pain in both sexes, but with enthesitis only in boys. Our data present new challenges for the ILAR classification of JIA.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2008 |
---|---|
Erschienen: |
2008 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
The Journal of rheumatology - 35(2008), 10 vom: 14. Okt., Seite 2055-61 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Berntson, Lillemor [VerfasserIn] |
---|
Themen: |
HLA-B27 Antigen |
---|
Anmerkungen: |
Date Completed 10.02.2009 Date Revised 21.11.2013 published: Print-Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM182366146 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM182366146 | ||
003 | DE-627 | ||
005 | 20231223162750.0 | ||
007 | tu | ||
008 | 231223s2008 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0608.xml |
035 | |a (DE-627)NLM182366146 | ||
035 | |a (NLM)18785306 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Berntson, Lillemor |e verfasserin |4 aut | |
245 | 1 | 0 | |a HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis |
264 | 1 | |c 2008 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 10.02.2009 | ||
500 | |a Date Revised 21.11.2013 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: Juvenile idiopathic arthritis (JIA) is a heterogeneous condition with very few clinical and laboratory signs that can help predict the course and severity of the disease in the individual patient. The cell-surface antigen HLA-B27 is well known to be associated with spondyloarthropathies, reactive arthritis, and enthesitis. HLA-B27 plays an important role in the classification of JIA, since evidence of sacroiliitis most often evolves after years of arthritis in other joints. We investigated the associations of HLA-B27 and the clinical manifestations of JIA using a method as close to a population-based study as possible | ||
520 | |a METHODS: We studied an incidence-based cohort of 305 patients collected prospectively in 3 Nordic countries (Sweden, Norway, Denmark). Clinical and serological data of the first 3 years of the disease were collected | ||
520 | |a RESULTS: HLA-B27 was found to be positive in 25.5% of the patients, and we found a higher proportion of HLA-B27-positive boys with older age at disease onset (p=0.034). Regression analysis showed a correlation of 0.7 in the HLA-B27-positive boys, pointing to a higher risk of more joint involvement with older age at disease onset. By Fisher's exact test, involvement of small joints in the lower extremities was associated with HLA-B27 in boys (p=0.011), but not in girls (p=0.687). HLA-B27 was associated with inflammatory back pain in both sexes (p=0.041 in boys, p=0.042 in girls), but with enthesitis only in boys (p<0.001 in boys, p=0.708 in girls) | ||
520 | |a CONCLUSION: HLA-B27 is of increasing importance with older age at disease onset in boys with JIA, predicting more active joints within the first 3 years of disease, and also involving small joints in the lower extremity to a greater degree than in HLA-B27-negative boys. During the first 3 years of disease the occurrence of HLA-B27 is associated with inflammatory back pain in both sexes, but with enthesitis only in boys. Our data present new challenges for the ILAR classification of JIA | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a HLA-B27 Antigen |2 NLM | |
700 | 1 | |a Damgård, Michael |e verfasserin |4 aut | |
700 | 1 | |a Andersson-Gäre, Boel |e verfasserin |4 aut | |
700 | 1 | |a Herlin, Troels |e verfasserin |4 aut | |
700 | 1 | |a Nielsen, Susan |e verfasserin |4 aut | |
700 | 1 | |a Nordal, Ellen |e verfasserin |4 aut | |
700 | 1 | |a Rygg, Marite |e verfasserin |4 aut | |
700 | 1 | |a Zak, Marek |e verfasserin |4 aut | |
700 | 1 | |a Fasth, Anders |e verfasserin |4 aut | |
700 | 0 | |a Nordic Paediatric Rheumatology Study Group |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of rheumatology |d 1983 |g 35(2008), 10 vom: 14. Okt., Seite 2055-61 |w (DE-627)NLM000019593 |x 1499-2752 |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2008 |g number:10 |g day:14 |g month:10 |g pages:2055-61 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 35 |j 2008 |e 10 |b 14 |c 10 |h 2055-61 |